Receptive Music Interventions During Intradermal Testing in Children
Launched by HILAL GUNGOR · Jun 2, 2025
Trial Information
Current as of July 24, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Children aged between 2 and 17 years
- • 2. Referred to the Pediatric Allergy Clinic for evaluation of suspected drug hypersensitivity reactions
- • 3. Accompanied by a parent or legal guardian willing to participate
- • 4. Written informed consent obtained from parents or legal guardians
- Exclusion Criteria:
- • 1. Known neurological, psychiatric, or developmental disorders in the child
- • 2. Use of sedatives or analgesic medications within 24 hours prior to testing
- • 3. Hearing impairment or auditory processing disorders in the child4.Non-consent or withdrawal of consent by parent or guardian
- • 4. Inability of the parent to complete anxiety assessments (e.g., due to language or cognitive barriers)
About Hilal Gungor
Hilal Gungor is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a focus on rigorous scientific methodology and ethical standards, Hilal Gungor collaborates with leading healthcare professionals and institutions to conduct clinical trials across various therapeutic areas. The organization emphasizes transparency, patient safety, and collaboration, striving to bring groundbreaking treatments from the laboratory to the clinic while fostering an environment of trust and integrity within the research community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, şişli, Turkey
Istanbul, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported